The Medicity, Gurgaon, recently named Best Private Hospital in India by Newsweek for the sixth consecutive year, has highlighted the urgent need for early detection and integrated treatment of coronary artery disease (CAD), valvular heart disease (VHD), and related renal ailments.
At a medical session in Itanagar, Dr. Praveen Chandra, Chairman of Interventional Cardiology at Medanta, stressed that minimally invasive surgeries, robotic procedures, and advanced interventions like TAVR and next-generation angioplasty have transformed outcomes for high-risk patients. “The benefits are greatest when disease is detected early. A proactive approach can prevent complications and save lives,” he said. Dr. Debabrata Mukherjee, Senior Director of Nephrology, explained the complex chain reaction linking heart, kidney, liver, and metabolic disorders, calling for a multidisciplinary approach. “We must address the root metabolic dysfunction, not just the symptoms,” he noted.
Patients and families increasingly seek advanced care outside the state due to limited tertiary facilities. Medanta’s announcement of an upcoming hospital in the city is expected to reshape the market by reducing medical outmigration and providing world-class treatment locally. Experts believe this will significantly boost healthcare access for the Northeast. Founded by Dr. Naresh Trehan, Medanta currently operates five hospitals and plans major expansions, including Guwahati, Mumbai, and Delhi.